
Emma Walmsley
Chief Executive Officer at Glaxosmithkline
False
Chief Executive Officer at Glaxosmithkline
Walmsley first joined GSK in 2010, initially working for the Consumer Healthcare, Europe, division. She became CEO in April 2017. 2019 was seen as a strong year for the company, with an increase in group sales, eight filings, six positive pivotal trial results, and four priority assets moving to phase II/III.
False
False
False